Tetrabenazine Treatment For Neurasthenia & Schizophrenia CAS 58-46-8

Unit Price: USD 1.0000 / Kilogram
Payment Type: T/T
Incoterm: CIF
Min. Order: 1 Kilogram
Delivery Time: 15 Days

Basic Info

Model No.: 58-46-8

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

TETRABENAZINE cas number 58-46-8 was synthesized as early as 1956 and was first approved by Switzerland for the treatment of neurasthenia and schizophrenia. Until 1980, tetrabenazine began to be used to treat various motor dysfunctions. In May 2008, it was approved by the US Food and Drug Administration (FDA) for the treatment of Huntington's disease, becoming the first and only drug in the United States to treat Huntington's disease.TETRABENAZINE cas 58-46-8 is a dopamine receptor blocker that inhibits the uptake of monoamines such as serotonin, dopamine and norepinephrine by reversibly binding to the central nervous system monoamine transporter 2 (VMAT2). Thereby producing pharmacological activity. The safety and efficacy of tetrabenazine and the absence of delayed dyskinesia are the main advantages of treating Huntington's disease.

Thera. Category: Dopamine Depleting Agent

Cas No.: 58-46-8

Synonyms:  (3R,11BR)-REL-1,3,4,6,7,11B-HEXAHYDRO-9,10-DIMETHOXY-3-(2-METHYLPROPYL)-2H-BENZO[A]QUINOLIZIN-2-ONE;TETRABENAZINE;2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)-rel-;9,10-Dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one;1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one;Nitoman;Ro 1-9569;Rubigen

Molecular Formula:  C19H27NO3

Molecular Weight: 317.42

58-46-8

Assay: ≥99%

PackingExport worthy packing

Material Safety Data SheetAvailable on request

Usage : Tetrabenazine CAS 58-46-8 is a drug for the symptomatic treatment of hyperkinetic movement disorder

Related intermediate:

1) Tetrabenazine 58-46-8

2) 6,7-Dimethoxy-3,4-dihydroisoquinoline hydrochloride 20232-39-7

3) 3-(N,N-Dimethylaminomethyl)-5-methyl-2-hexanone 91342-74-4


Active Pharmaceutical Ingredients> Cas 90098-04-7,Rebamipide Named In Mucosta With GMP Standard
Active Pharmaceutical Ingredients> Functional Dyspepsia Treatment Acotiamide Hydrochloride Trihydrate CAS 773092-05-0
Active Pharmaceutical Ingredients> Acotiamide Hydrochloride For Gastric Motility Improvement CAS 185104-11-4
Contract Manufacturing> ASCORBYL GLUCOSIDE Used for Comesitc Additive CAS 129499-78-1
Pharmaceutical Intermediates> Anti-Ulcerative> 2-Aminothiazole-4-ethylformate For Making Acotiamide Cas 5398-36-7
Pharmaceutical Intermediates> Anti-Ulcerative> Acotiamide INT CAS NUMBER 185105-98-0
Pharmaceutical Intermediates> Anti-Cardiovascular> Azilsartan Used for Hypertension Treatment CAS 147403-03-0
Pharmaceutical Intermediates> Anti-Diabetes> Sitagliptin Phosphate Monohydrate Treated for Type 2 diabetes CAS Number 654671-77-9
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 132210-24-3, 2-Amino-3-(1,2-dihydro-2-oxo-quinoline-4-yl)Propanoic acid Hydrochloride For Rebamipide
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 1068-90-2 White Crystalline Powder Diethyl Acetamidomalonate For Rebamipide(DAAM)
Active Pharmaceutical Ingredients> 6027-23-2, Hordenine HCL Powder
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 4876-10-2,4-Bromomethyl-2(1H)-quinolinone (BMQ) For Rebamipide/ Mucosta
Pharmaceutical Intermediates> Anti-Respiratory> CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> 312753-53-0, Indacaterol Intermediate
Pharmaceutical Intermediates> Anti-Respiratory> 100331-89-3, Indacaterol Intermediate

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html